These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26350104)

  • 1. Physiologically-Based Pharmacokinetic and Pharmacodynamic Modeling for the Inhibition of Acetylcholinesterase by Acotiamide, A Novel Gastroprokinetic Agent for the Treatment of Functional Dyspepsia, in Rat Stomach.
    Yoshii K; Iikura M; Hirayama M; Toda R; Kawabata Y
    Pharm Res; 2016 Feb; 33(2):292-300. PubMed ID: 26350104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acotiamide Hydrochloride, a Therapeutic Agent for Functional Dyspepsia, Enhances Acetylcholine-induced Contraction via Inhibition of Acetylcholinesterase Activity in Circular Muscle Strips of Guinea Pig Stomach.
    Ito K; Kawachi M; Matsunaga Y; Hori Y; Ozaki T; Nagahama K; Hirayama M; Kawabata Y; Shiraishi Y; Takei M; Tanaka T
    Drug Res (Stuttg); 2016 Apr; 66(4):196-202. PubMed ID: 26418413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of acotiamide, an orally active acetylcholinesterase inhibitor, into the myenteric plexus of rat and dog stomachs.
    Yoshii K; Yamaguchi T; Hirayama M; Toda R; Kinomoto T; Kawabata Y; Chiba K
    Life Sci; 2016 Jan; 145():93-7. PubMed ID: 26682939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats.
    Kawachi M; Matsunaga Y; Tanaka T; Hori Y; Ito K; Nagahama K; Ozaki T; Inoue N; Toda R; Yoshii K; Hirayama M; Kawabata Y; Takei M
    Eur J Pharmacol; 2011 Sep; 666(1-3):218-25. PubMed ID: 21651906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for distribution of acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach.
    Yoshii K; Hirayama M; Nakamura T; Toda R; Hasegawa J; Takei M; Mera Y; Kawabata Y
    J Pharm Sci; 2011 Nov; 100(11):4965-73. PubMed ID: 21630282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs.
    Nagahama K; Matsunaga Y; Kawachi M; Ito K; Tanaka T; Hori Y; Oka H; Takei M
    Neurogastroenterol Motil; 2012 Jun; 24(6):566-74, e256. PubMed ID: 22429221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia.
    Tack J; Janssen P
    Expert Opin Investig Drugs; 2011 May; 20(5):701-12. PubMed ID: 21417958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Uptake Transporter Responsible for Distribution of Acotiamide into Stomach Tissue.
    Hirayama M; Hoshino Y; Yoshii K; Toda R; Kawabata Y; Nakanishi T; Tamai I
    Mol Pharm; 2020 Apr; 17(4):1071-1078. PubMed ID: 32105080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
    Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
    Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acotiamide improves stress-induced impaired gastric accommodation.
    Ikeo K; Oshima T; Sei H; Kondo T; Fukui H; Watari J; Miwa H
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27860042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia.
    Suzuki H; Hibi T
    Neurogastroenterol Motil; 2010 Jun; 22(6):595-9. PubMed ID: 20553562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acotiamide on gastric emptying in healthy adult humans.
    Zai H; Matsueda K; Kusano M; Urita Y; Saito Y; Kato H
    Eur J Clin Invest; 2014 Dec; 44(12):1215-21. PubMed ID: 25370953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging treatments in neurogastroenterology: Acotiamade, a novel treatment option for functional dyspepsia.
    Matsushita M; Masaoka T; Suzuki H
    Neurogastroenterol Motil; 2016 May; 28(5):631-8. PubMed ID: 26730749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia.
    Nakamura K; Tomita T; Oshima T; Asano H; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Ohda Y; Fukui H; Kazuhito F; Hirota S; Watari J; Miwa H
    J Gastroenterol; 2017 May; 52(5):602-610. PubMed ID: 27639387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats.
    Seto K; Sasaki T; Katsunuma K; Kobayashi N; Tanaka K; Tack J
    Neurogastroenterol Motil; 2008 Sep; 20(9):1051-9. PubMed ID: 18482254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological and clinical profile of acotiamide hydrochloride hydrate (Acofide(®) Tablets 100 mg), a novel therapeutic agent for functional dyspepsia (FD)].
    Matsunaga Y; Tanaka T; Saito Y; Kato H; Takei M
    Nihon Yakurigaku Zasshi; 2014 Feb; 143(2):84-94. PubMed ID: 24531902
    [No Abstract]   [Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage.
    Matsueda K; Hongo M; Tack J; Aoki H; Saito Y; Kato H
    Neurogastroenterol Motil; 2010 Jun; 22(6):618-e173. PubMed ID: 20059698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acotiamide for the treatment of functional dyspepsia.
    Sun Y; Song G; McCallum RW
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1161-8. PubMed ID: 24881488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.